2010
DOI: 10.1016/s1098-3015(10)71993-8
|View full text |Cite
|
Sign up to set email alerts
|

Ht1 Comparative-Effectiveness Versus Cost-Effectiveness: A Comparison of the French and Scottish Approaches to Single Technology Assessment (Sta)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2012
2012

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…For example, compared to NICE, the TLV was more willing to consider need over cost, as intimated earlier, approving drugs beyond the threshold, up to £75,000, when there is high clinical need in certain sub-populations. Other research (Bending, Hutton and McGrath, 2010;Patel et al, 2010) on cancer drugs substantiates the influence of evidence requirements, where agencies (i.e. NICE) focused on cost-effectiveness less frequently gave positive recommendations (about 50%) compared with those only requiring evidence of clinical effectiveness (i.e.…”
Section: Applying Evidence To Decision Makingmentioning
confidence: 99%
“…For example, compared to NICE, the TLV was more willing to consider need over cost, as intimated earlier, approving drugs beyond the threshold, up to £75,000, when there is high clinical need in certain sub-populations. Other research (Bending, Hutton and McGrath, 2010;Patel et al, 2010) on cancer drugs substantiates the influence of evidence requirements, where agencies (i.e. NICE) focused on cost-effectiveness less frequently gave positive recommendations (about 50%) compared with those only requiring evidence of clinical effectiveness (i.e.…”
Section: Applying Evidence To Decision Makingmentioning
confidence: 99%